Pentopril

This classification denotes an ace inhibitor with the molecular formula C18H23NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z99269057A, chemically known as 1h-indole-1-pentanoic acid, 2-carboxy-2,3-dihydro-alpha,gamma-dimethyl-delta-oxo-, ethyl ester, (2s-(1(alphas*,gammas*),2r*))- but generally known as pentopril, which bears US NIH Compound Identifier 54938. European Medicines Agency schedules Pentopril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09702MIG. The term PENTOPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). PENTOPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pentopril under HS 29339990 and SITC 51577. As of Q4 2014, PENTOPRIL remains the US FDA Preferred Term for this commodity. Pentopril bears US NLM identifiers UMLS ID C0135946 and NCI Concept Code C72909. SMILES: O=C(N1C(Cc2c1cccc2)C(=O)O)C(CC(C)C(=O)OCC)C.